RAB37 Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0532
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability

Cancer Research
Cancer ResearchOncology
2018English

A Pairwise Meta‐Analysis of Induction Chemotherapy in Nasopharyngeal Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Nasopharyngeal Carcinoma With Bone Marrow Metastasis: Positive Response to Weekly Paclitaxel Chemotherapy

Internal Medicine
Internal MedicineMedicine
2015English

Interim Analysis of a Prospective Randomized Non-Inferiority Trial of Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Nasopharyngeal Carcinoma

Oncotarget
Oncology
2016English

Manganese Superoxide Dismutase Mediates Anoikis Resistance and Tumor Metastasis in Nasopharyngeal Carcinoma

Oncotarget
Oncology
2016English

A Prognostic Bio-Model Based on SQSTM1 and N Stage Identifies Nasopharyngeal Carcinoma Patients at High Risk of Metastasis for Additional Induction Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2017English

MicroRNA-23b Regulates Nasopharyngeal Carcinoma Cell Proliferation and Metastasis by Targeting E-Cadherin

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

miR-185-3p Regulates the Invasion and Metastasis of Nasopharyngeal Carcinoma by Targeting WNT2B In�vitro

Oncology Letters
Cancer ResearchOncology
2017English

LncRNA SNHG1 Negatively Regulates miR-145a-5p to Enhance NUAK1 Expression and Promote Cancer Cell Metastasis and Invasion in Nasopharyngeal Carcinoma

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy